Selenium deficiency contributes to the chronic myocarditis in coxsackievirus-infected mice

Acta Virologica

Volumn 55, Issue 1, 2011, Pages 23-29

  Jun, E J ^a   Ye, J S ^a   Hwang, I S ^a   Kim, Y K ^a   Lee, H ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Coxsackievirus B3; Glutathione peroxidase; Mice; Myocarditis; Selenium deficiency; Viral RNA

Indexed keywords

GLUTATHIONE PEROXIDASE; VIRUS RNA; SELENIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; COXSACKIE VIRUS B3; COXSACKIE VIRUS INFECTION; DISEASE ASSOCIATION; DISEASE SEVERITY; HISTOPATHOLOGY; MALE; MORTALITY; MOUSE; MYOCARDITIS; NONHUMAN; SELENIUM DEFICIENCY; VIRUS REPLICATION; ANIMAL; BLOOD; CARDIOMYOPATHY; CERCOPITHECUS; ENTEROVIRUS; ENTEROVIRUS INFECTION; GENETICS; HEART; HEART MUSCLE; METABOLISM; PATHOLOGY; PHYSIOLOGY; VERO CELL; VIROLOGY;

COXSACKIEVIRUS; MUS;

ANIMALS; CARDIOMYOPATHIES; CERCOPITHECUS AETHIOPS; COXSACKIEVIRUS INFECTIONS; ENTEROVIRUS; ENTEROVIRUS INFECTIONS; GLUTATHIONE PEROXIDASE; HEART; MICE; MYOCARDITIS; MYOCARDIUM; RNA, VIRAL; SELENIUM; VERO CELLS;

EID: 79957544733     PISSN: 0001723X     EISSN: None     Source Type: Journal    
DOI: 10.4149/av_2011_01_23     Document Type: Article

References (29)

1. Beck MA (2007): Selenium and vitamin E status: impact on viral pathogenicity. J. Nutr. 137, 1338-1340.
2. Beck MA, Esworthy RS, Ho YS, Chu FF (1998): Glutathione peroxidase protects mice from viral-induced myocarditis. FASEB J. 12, 1143-1149.
3. Beck MA, Kolbeck PC, Rohr LH, Shi Q, Morris VC, Levander OA (1994): Benign human enterovirus becomes virulent in selenium-deficient mice. J. Med. Virol. 43, 166-170.
4. Beck MA, Levander OA, Matthews CC (2003): Selenium deficiency and viral infection. J. Nutr. 133 (Suppl.), 1463S-1467S.
5. Beck MA, Matthews CC (2000): Micronutrients and host resistance to viral infection. Proc. Nutr. Soc. 59, 581-585.
6. Beck MA, Shi Q, Morris VC, Levander A (1995): Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates. Nat. Med. 1, 433-436.
7. Chandra RK (1990): Micronutrients and immune functions. An overview. Ann. NY Acad. Sci. 587, 9-16.
8. Davies KJ, Lin SW, Pacifici RE (1987): Protein damage and degradation by oxygen radicals. IV. Degradation of denatured protein. J. Biol. Chem. 262, 9914-9920.
9. Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA (Ed.) (2005): Virus Taxonomy: Eight Report of the International Committee on Taxonomy of Viruses. New York, Elsevier Academic Press.
10. Ge K, Xue A, Bai J, Wang S (1983): Keshan disease-an endemic cardiomyopathy in China. Virchows Arch. A Pathol. Anat. Histopathol. 401, 1-15.
11. Good RA, Lorenz E (1992): Nutrition and cellular immunity. Int. J. Immunopharmacol. 14, 361-366.
12. Herskowitz A, Wolfgram LJ, Rose NR, Beisel W (1987): Coxsackievirus B3 murine myocarditis: a pathologic spectrum of myocarditis in genetically defined inbred strains. J. Am. Coll. Cardiol. 9, 1311-1319.
13. Huber SA, Lodge PA (1986): Coxsackievirus B-3 myocarditis. Identification of different pathogenic mechanisms in DBA/2 and Balb/c mice. Am. J. Pathol. 122, 284-291.
14. Joo CH, Hong HN, Kim EO, Im JO, Yoon SY, Ye JS, Moon MS, Kim D, Lee H, Kim YK (2003): Coxsackievirus B3 induces apoptosis in the early phase of murine myocarditis: a comparative analysis of cardiovirulent and noncardiovirulent strains. Intervirology 46, 135-140.
15. Leslie K, Blay R, Haisch C, Lodge A, Weller A, Huber S (1989): Clinical and experimental aspects of viral myocarditis. Clin. Microbiol. Rev. 2, 191-203.
16. Li Y, Peng T, Yang Y, Niu C, Archard LC, Zhang H (2000): High prevalence of enteroviral genomic sequences in myocardium from cases of endemic cardiomyopathy (Keshan disease) in China. Heart 83, 696-701.
17. Moon MS, Joo CH, Hwang IS, Ye JS, Jun EJ, Lee HS, Kim D, Lee MJ, Lee H, Kim YK (2005): Distribution of viral RNA in mouse tissues during acute phase of coxsackievirus B5 infection. Intervirology 48, 153-160.
18. Muir P (1993): Enteroviruses and heart disease. Br. J. Biomed. Sci. 50, 258-271.
19. Mygind T, Birkelund S, Falk E, Christiansen G (2001): Evaluation of real-time quantitative PCR for identification and quantification of Chlamydia pneumoniae by comparison with immunohistochemistry. J. Microbiol. Methods 46, 241-251.
20. Pallansch MA, Roos MA (Ed.) (2001): Enteroviruses : Poliovirus, Coxsackieviruses, Echoviruses, and Newer Enteroviruses. New York, Field Virology.
21. Reetoo KN, Osman SA, Illavia SJ, Cameron-Wilson CL, Banatvala JE, Muir P (2000): Quantitative analysis of viral RNA kinetics in coxsackievirus B3-induced murine myocarditis: biphasic pattern of clearance following acute infection, with persistence of residual viral RNA throughout and beyond the inflammatory phase of disease. J. Gen. Virol. 81, 2755-2762.
22. Rivett AJ (1985): The effect of mixed-function oxidation of enzymes on their susceptibility to degradation by a nonlysosomal cysteine proteinase. Arch. Biochem. Biophys. 243, 624-632.
23. Roivainen M (1999): Enteroviruses and myocardial infarction. Am. Heart. J. 138, S479-483.
24. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG (1973): Selenium: biochemical role as a component of glutathione peroxidase. Science 179, 588-590.
25. Stadtman ER (1992): Protein oxidation and aging. Science 257, 1220-1224.
26. Stadtman TC (2000): Selenium biochemistry. Mammalian selenoenzymes. Ann. NY Acad. Sci. 899, 399-402.
27. Stephen AI, Avenell A (2006): A systematic review of multivitamin and multimineral supplementation for infection. J. Hum. Nutr. Diet. 19, 179-190.
28. Steven Tracy MSO, Drescher KM (Ed.) (2008): Group B Coxsackieviruses, Springer.
29. Woodruff JF (1980): Viral myocarditis. A review. Am. J. Pathol. 101, 425-484.